Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosisBinoy Yohannan, Eli Muchtar, Prashant Kapoor et al.|Blood Neoplasia|2025Cited by 18
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Ashutosh Wechalekar, Amy A. Kirkwood et al.|Journal of Clinical Oncology|2025Cited by 8